Where medicine, business, and public policy intersect.
Publication/Presentation Date
2-1-2007
Abstract
Molecular biomarkers are emerging as key indices for the management of patients with cancer and other significant diseases, but their potential has yet to be fully realized. Is there enough collaboration in place to optimize this care revolution?
Volume
4
Issue
1
First Page
33
Last Page
42
ISSN
1554-169X
Published In/Presented At
Wilson, C. L., Schultz, S., & Waldman, S. A. (2007). Where medicine, business, and public policy intersect. Biotechnology healthcare, 4(1), 33–42.
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
23397413
Department(s)
Administration and Leadership
Document Type
Article
COinS